Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,299 total articles
SoFi Technologies general counsel Robert S. Lavet bought 5,000 shares of the company's stock on February 6, 2026, according to a Form 4 filing. The purchase was executed at $21.044 per share for a total of $105,220. Following the transaction, Lavet indirectly holds 17,172 shares through the Robert S. Lavet Trust. The insider move comes after SoFi r…
Cynthia L. Tregillis, Western Digital's Chief Legal Officer and Corporate Secretary, sold 6,780 shares of the company on February 6, 2026, at $270.49 per share, for roughly $1.83 million. The transaction leaves her with 136,538 directly held shares. The sale comes as Western Digital rolled out a 40TB UltraSMR ePMR drive and outlined roadmaps to 60T…
Matthew E. Massengill, a director at Western Digital Corp, sold 39,513 shares on February 5, 2026, in transactions executed under a pre-arranged Rule 10b5-1 plan, totaling $9,616,465. The company has concurrently been the subject of multiple analyst target changes and reiterated growth expectations tied to AI-driven data expansion and new hard driv…
Syndax Pharmaceuticals CEO Michael A. Metzger sold 7,412 shares on Feb. 6, 2026 for $20.62 apiece, generating $152,835 in proceeds. The company’s shares have risen 63% over six months and trade near $21.01. Recent corporate disclosures show significant stock grants and option awards to Metzger on Feb. 4, while clinical data and analyst buy ratings …
Director Blake Borgeson sold 220,000 shares of Recursion Pharmaceuticals on February 3, 2026, for $4.20 per share, a transaction valued at $924,000 executed under a Rule 10b5-1 trading plan. The sale occurred while the stock has declined 5% over the past week and 45% year-over-year, trading at $3.96 — below Borgeson’s sale price. Post-sale, Borgeso…
Recursion Pharmaceuticals director Christopher Gibson executed a planned sale of Class A shares that generated $164,800 and completed a Class B-to-A conversion, followed days later by a stock-based acquisition to cover tax obligations. The transactions occur against a backdrop of a 45% year-over-year share decline, weak company financial metrics, a…
Syndax Pharmaceuticals Chief Financial Officer Keith A. Goldan completed a mix of share transactions in late January and early February 2026, including a sale of 2,082 shares for roughly $42,930, several zero-priced transfers, and an option award. The company also disclosed encouraging clinical results for its menin inhibitor Revuforj presented at …
Glenbrook Capital Management, already a roughly 10% holder of SenesTech, Inc. (NASDAQ: SNES), acquired 8,569 additional shares in two open-market transactions valued at $15,479, according to a Form 4 filing. The purchases were split between February 4 and February 5, 2026. Separately, SenesTech reported a 43% rise in revenue for the third quarter o…
Qualys Chief Financial Officer Kim Joo Mi sold 7,199 shares of common stock on February 4, 2026, under a pre-arranged 10b5-1 trading plan, generating $873,369. The company also reported fourth-quarter 2025 results that exceeded consensus on both earnings per share and revenue, even as Truist Securities cut its price target and flagged a slight dip …
Live Oak Bancshares Chief Executive James S. Mahan III, acting through the James S. Mahan Revocable Trust, sold 20,000 shares of the bank's voting common stock on February 4 and 5, 2026, realizing about $821,072. The transactions took place under a Rule 10b5-1 trading plan and coincided with a period of notable share-price appreciation and better-t…
Ryan Marshall, Chief Executive Officer and President of PulteGroup, executed multiple transactions in early February 2026 that include the sale of 111,250 shares on Feb. 5 for roughly $14.8 million and additional disposition and acquisition activity on Feb. 4. A Form 4 filing details the trades and the executive's remaining direct and indirect hold…
Gilead Sciences CEO Daniel Patrick O’Day sold 115,640 shares of common stock on February 5, 2026, at $150.00 per share, receiving $17,346,000, and simultaneously exercised options to acquire the same number of shares at $66.01 for a value of $7,633,396. The transactions were carried out under a Rule 10b5-1 trading plan adopted February 28, 2025. Se…
Ahmad Bahai, a senior vice president at Texas Instruments Inc., sold 3,000 shares of TXN on Feb. 5, 2026, for roughly $670,386 after exercising options to acquire another 3,000 shares at $79.26. The stock was trading near its 52-week high while company results for Q4 2025 slightly missed estimates and management announced an all-cash acquisition of…
Jane Grebenc, Executive Vice President and Chief Revenue Officer of First Commonwealth Financial Corp (NYSE: FCF), sold 7,402 shares of the bank’s common stock on February 5, 2026, in two transactions totaling $138,904. The trades occurred while FCF shares traded close to their 52-week high. The company reported a narrow fourth-quarter 2025 earning…
A director of Peoples Bancorp of North Carolina Inc. sold 600 shares on February 4, 2026, realizing $22,362. The bank has since seen its share price rise to $38.63 and declared a special cash dividend of $0.17 per share, payable on February 13, 2026 to holders of record as of February 4, 2026. The shares trade modestly above their Fair Value per In…
Joyce Thomas Patrick Jr., a director at Roper Technologies, purchased 1,400 shares of the company's common stock on February 6, 2026, in trades totaling $501,844. The purchases were executed at prices between $358.34 and $358.50, with an average execution price reported as $358.46. After the transactions, Patrick directly holds 3,775 Roper shares w…
Kirby Corp (KEX) Vice President and Controller Ronald A. Dragg sold 5,429 shares on February 4, 2026, for $122 each, netting $662,338, and exercised options to acquire 2,787 shares at $73.29 for $204,259. The company, trading near $123 and valued at $6.67 billion, has seen nearly 18% share appreciation over six months and is viewed by analysts as a…
Liberty All Star Equity Fund treasurer Erich Rettinger purchased 350 shares on February 6, 2026, at $6.01 per share for a total of $2,103. The fund is trading near $6.03, carries a market capitalization of $1.78 billion, yields 12.12% in dividends and has paid dividends for 40 consecutive years. The fund shows a P/E ratio of 8.87 and a 'GOOD' overa…
Erich Rettinger, Treasurer of LIBERTY ALL STAR GROWTH FUND INC., purchased 250 shares on February 6, 2026, at $5.12 per share for a total of $1,280. The fund currently trades at $5.16 and shows a 9.49% dividend yield, a market capitalization of $319.4 million, a P/E of 9.12 and a 'GOOD' financial health rating according to InvestingPro data. ASG ha…
David A. Ayoub, a director at Pathfinder Bancorp, purchased 425 shares of the company's common stock on February 4, 2026, at $12.83 per share for a total of $5,452. The transaction modestly increases his direct holdings while the company continues to pay a long-running dividend and trades below book value.
Broadridge Financial Solutions director Robert N. Duelks sold 253 shares of company stock on February 6, 2026, for $48,727. The transaction was disclosed in a Form 4 filing signed by Maria Allen, Power of Attorney. The company recently beat second-quarter fiscal 2026 estimates, raised full-year earnings guidance and announced an agreement to acquir…
Director Edwards Murray Hamilton purchased 500 shares of First Financial Bankshares (NASDAQ: FFIN) on February 5, 2026, spending $17,090 at $34.18 per share. The transaction adjusts his direct and indirect holdings, and comes amid a management succession that elevated James Alexander to Executive Vice President and Head of Commercial Banking while …
Hilary J. Spann, Executive Vice President of BXP, Inc., sold 1,194 shares of common stock on February 5, 2026, for $63.31 per share, generating proceeds of $75,592. Following the sale, Spann holds 17,832 shares. Separately, BXP reported fourth-quarter 2025 earnings of $1.56 per share, exceeding the $0.49 consensus estimate, though the stock traded …
Provident Financial Services Executive Chairman Christopher P. Martin sold 1,050 shares on February 5, 2026, at $23.45 per share for proceeds of $24,622. The transaction occurs while the bank's shares trade close to a 52-week high and after the company reported fourth-quarter 2025 results that topped analyst expectations for both EPS and revenue.
Horizon Kinetics Asset Management LLC, a roughly 10% holder of Texas Pacific Land Corp (TPL), recorded a purchase of a single common share on February 5, 2026, at $341.52. The firm now directly holds 3,479,367 shares. Separately, Texas Pacific Land released Q3 2025 results that fell short of analyst expectations and disclosed a strategic partnershi…
